Endoscopic sphincterotomy for delaying choLecystectomy in mild acute biliarY pancreatitis (EMILY study): Protocol of a multicentre randomised clinical trial

Levente, Kucserik, Marta, Katalin, Vincze, Aron, Lazar, Gyorgy, Czako, Laszlo, Szentkereszty, Zsolt, Papp, Maria, Palatka, Karoly, Izbeki, Ferenc, Altorjay, Aron, Torok, Imola, Sorin, Barbu, Tantau, Marcel, Vereczkei, Andras, Bogar, Lajos, Denes, Marton, Imola, Nemeth, Andrea, Szentesi, Zadori, Noemi, Antal, Judit, Lerch, Markus, Neoptolemos, John, Sahin-Toth, Miklos, Petersen, Ole ORCID: https://orcid.org/0000-0002-6998-0380, Kelemen, Dezso and Hegyi, Peter 2019. Endoscopic sphincterotomy for delaying choLecystectomy in mild acute biliarY pancreatitis (EMILY study): Protocol of a multicentre randomised clinical trial. BMJ Open 9 , e025551. 10.1136/bmjopen-2018-025551

PDF - Published Version Available under License Creative Commons Attribution Non-commercial. Download (1MB)

Abstract

Introduction: According to the literature, early cholecystectomy is necessary to avoid complications related to gallstones after an initial episode of acute biliary pancreatitis (ABP). A randomised, controlled multicentre trial (the PONCHO trial) revealed that in the case of gallstone-induced pancreatitis, early cholecystectomy was safe in patients with mild gallstone pancreatitis and reduced the risk of recurrent gallstone-related complications, as compared with interval cholecystectomy. We hypothesise that carrying out a sphincterotomy (ES) allows us to delay cholecystectomy, thus making it logistically easier to perform and potentially increasing the efficacy and safety of the procedure. Methods/Design: EMILY is a prospective, randomised, controlled multicentre trial. All patients with mild ABP, who underwent ES during the index admission or in the medical history will be informed to take part in EMILY study. The patients will be randomised into two groups: (1) early cholecystectomy (within 6 days after discharge) and (2) patients with delayed (interval) cholecystectomy (between 45 and 60 days after discharge). During a 12-month period, 93 patients will be enrolled from participating clinics. The primary endpoint is a composite endpoint of mortality and recurrent acute biliary events (that is, recurrent ABP, acute cholecystitis, uncomplicated biliary colic and cholangitis). The secondary endpoints are organ failure, biliary leakage, technical difficulty of the cholecystectomy, surgical and other complications.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences
Publisher:	BMJ Publishing Group
ISSN:	2044-6055
Related URLs:	Publisher
Date of First Compliant Deposit:	30 July 2019
Date of Acceptance:	2 May 2019
Last Modified:	05 May 2023 03:22
URI:	https://orca.cardiff.ac.uk/id/eprint/124583

Citation Data

Cited 4 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item